Cargando…
What is New on Thyroid Cancer Biomarkers
Thyroid cancer harbours in about 5% of thyroid nodules. The majority of them are well-differentiated cancers originating from the follicular epithelium, and are subdivided into papillary and follicular carcinomas. Undifferentiated carcinomas and medullary thyroid carcinomas arising from C cells are...
Autores principales: | Ruggeri, Rosaria M., Campennì, Alfredo, Baldari, Sergio, Trimarchi, Francesco, Trovato, Maria |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688342/ https://www.ncbi.nlm.nih.gov/pubmed/19578508 |
Ejemplares similares
-
Hepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic Target
por: Trovato, Maria, et al.
Publicado: (2017) -
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
por: Campennì, Alfredo, et al.
Publicado: (2022) -
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis
por: Trovato, Maria, et al.
Publicado: (2017) -
Undetectable or low (<1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients
por: Campennì, Alfredo, et al.
Publicado: (2018) -
HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
por: Ruggeri, Rosaria M., et al.
Publicado: (2016)